Navigation Links
Waging War on Wrinkles: Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport - The Botox Alternative
Date:7/19/2009

Infini Cosmetic Associates in Scottsdale will carry Dysport™ the newly FDA approved wrinkle remover and rival to Botox®. Founder and Chief Surgeon, Dr. William Hall has performed thousands of injections over the last six years and trained many other professionals on Botox® and other injectable dermal fillers. Dr. Hall is very skilled in many of the advanced uses of Botox for: hyperhidrosis (excessive sweating) and nervous tics in the face, neck bands and wrinkles, chin creases and dimpling, lip lines, and lower facial shaping.

Scottsdale, AZ (PRWEB) July 19, 2009 -- Dr. William Hall, Founder and Chief Surgeon at Infini Cosmetic Associates in Scottsdale, announced that Infini Cosmetic Associates will carry Dysport™ the newly FDA approved wrinkle remover and rival to Botox®. Dr. Hall has performed thousands of injections over the last six years and trained many other professionals on Botox® and other injectable dermal fillers. Dr. Hall is very skilled in many of the advanced uses of Botox for: hyperhidrosis (excessive sweating) and nervous tics in the face, neck bands and wrinkles, chin creases and dimpling, lip lines, and lower facial shaping.

The arrival of Dysport™ into the U.S. aesthetics marketplace will no doubt increase competition between the two wrinkle treatments and multiply physician choices and cosmetic options within the same medical practice.

"This is a burgeoning industry and dermal fillers are very popular, so as doctors we are always being introduced to new products that compete with ones we already use - for example I use both Restylane® and Juvederm®," Hall stated. "I have used and trained with Botox® for years and patients love the results, I will offer Dysport™ too, but ultimately, the patients decide after they try both products and see the lasting results," Dr. Hall concluded.

Medicis, a dermal filler leader (known for their popular Restylane® and Perlane® facial fillers) will promote the Dysport™ brand as part of a U.S. sales agreement with the manufacturer, Ipsen. The addition of Dysport™ to their dermal filler arsenal positions Medic as a threatening opponent to the Allergan empire and their line of beauty treatments (Botox® and the Juvederm® - hyaluronic acid gel fillers).

BOTOX® Cosmetic is the solution for many wrinkles, which are actually creases that have been worn into the skin by making the same expression thousands of times. Hall explains - "expression lines" are often called frown lines, crow's feet, or forehead lines and appear due to the contraction of a muscle under the skin in that area. BOTOX® Cosmetic offers a much safer, less invasive option than cutting the muscle and provides more predictable and enhanced results. Some have called this unique therapy "a facelift in a bottle." Now, with Dysport™ there are more products to wage war on age.

Botox and dermal fillers produce long-lasting, amazing results. Visit http://www.infiniskin.com/Wrinkles.html to find out more about wrinkle restoration. For more information about Infini Cosmetic Associates, visit www.infiniskin.com to see photo galleries and the amazing special offers on Botox and dermal fillers. To set up a free consultation, call 480-946-7100.

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2655704.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. StructuRad Launches MacroLive(TM) with INFINITT and RamSoft at RSNA 2007
2. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
3. Management Consultancy Announces Inaugural Infinitive Championship Series
4. AutoGenomics INFINITI Analyzer Receives Artistic Design Award
5. Infinity Business Systems of Tampa Expands Into Sarasota / Bradenton
6. Thank You, Dunder Mifflin Infinity
7. Infinity Property and Casualty Corporation Declares Quarterly Dividend
8. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
9. ProStor InfiniVault-DICOM Storage System Debuts in Rorke Data Booth at RSNA
10. Shaklee Hits the Road With Its Infinite Possibilities Tour
11. Shaklee Hits the Road with its Infinite Possibilities Tour in New York, NY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... ... Braun Industries will be participating as an exhibitor at EMS Today 2017. ... 23-25, 2017 at the Calvin L. Rampton Salt Palace Convention Center in Salt Lake ... on display. , “JEMS is a leader in EMS news and education. ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... in better care, and MEDfx and the Delaware Health Information Network (DHIN) have ... As the nation’s first state-wide health information exchange, DHIN stores and shares real-time ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Axendia, **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. – 2:30 ... regulatory burden? Pay dividends in enhanced and predictable product performance? Streamline processes ...
(Date:2/18/2017)... ... 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing ... Ken was impressed with the safety and reliability of the Stannah Stairlift as ... show. This endorsement by Ken Matthews can be heard on News Radio WHP ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Research and Markets has announced the addition of ... report to their offering. ... Traditional medical devices include devices (e.g., ... implantables, large endoscopes, needle based drug delivery, lab based diagnostics ... to three decades for the treatment and management of various ...
(Date:2/16/2017)... -- DaVita Inc. (NYSE: DVA ) today announced ... Net income attributable to DaVita Inc. for ... million, or $0.80 per share and $880 million, or $4.29 ... to DaVita Inc. for the quarter and year ended December ... million, or $0.98 per share, and $789 million, or $3.85 ...
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
Breaking Medicine Technology: